Trading Ideas Genmab A/S

Equities

GMAB

DK0010272202

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:58 2024-05-17 am EDT			5-day change	1st Jan Change
2,041 ^DKK	+0.74%		+1.90%	-5.29%

May. 15	Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation'	MT
May. 15	Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50%	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GENMAB A/S :The comeback of an upward trend can be anticipated	Mar. 11
GENMAB A/S :Expectation of a turn-around	Jan. 25
GENMAB A/S :Expectation of a turn-around	Jan. 04
GENMAB A/S :The comeback of an upward trend can be anticipated	Dec. 08
GENMAB A/S :Technically solid	22-11-16
GENMAB A/S :Buyers are coming back	22-08-12
GENMAB A/S :Comeback of a rising trend?	22-03-31
GENMAB A/S :The underlying trend is to the upside	20-06-15
GENMAB A/S :The underlying trend is to the upside	20-01-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab: A good start to 2024; guidance unchanged

GENMAB : A good start to 2024; guidance unchanged

May 03, 2024 at 01:08 pm EDT

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW